Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia.
about
Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotypeCDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerEssential role of gastric gland mucin in preventing gastric cancer in miceSox2 is essential for formation of trophectoderm in the preimplantation embryo.Risk factors of gastric cancer specific for tumor location and histology in Cali, Colombia.Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection.Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancerAnimal models of stomach carcinogenesis.Epithelial BMP signaling is required for proper specification of epithelial cell lineages and gastric endocrine cells.Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.Apoptotic cell death and its relationship to gastric carcinogenesis.Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancerFatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice.Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathyRunx3 controls growth and differentiation of gastric epithelial cells in mammals.Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.Molecular pathobiology of gastric cancer.Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features.DNA methylation: a marker for carcinogen exposure and cancer riskGenetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma.Clinicopathologic significance of gastric and intestinal phenotypic marker expression in gastric carcinomas.Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.Field cancerization in the GI tract.Helicobacter pylori infection and gastric carcinogenesis in rodent models.Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment.Helicobacter pylori-Induced Signaling Pathways Contribute to Intestinal Metaplasia and Gastric Carcinogenesis.H. pylori induces the expression of Hath1 in gastric epithelial cells via interleukin-8/STAT3 phosphorylation while suppressing Hes1.Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line.Phosphorylation of the gastric tumor suppressor RUNX3 following H. pylori infection results in its localization to the cytoplasm.Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results.Homeostatic mass control in gastric non-neoplastic epithelia under infection of Helicobacter pylori: an immunohistochemical analysis of cell growth, stem cells and programmed cell deathBile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells.In vitro differentiation of Runx3-/- p53-/- gastric epithelial cells into intestinal type cells.Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.The time to eradicate gastric cancer is now
P2860
Q26825103-4881E672-ECE8-43C2-B348-5687541B758BQ28251382-EAB9191D-061A-4D19-AA46-5A203F7AEB25Q28504503-DD54F098-CE9D-478C-A427-5D0E53184011Q33754449-6CDF136A-EB33-47BC-BEED-13C15CA9909DQ33909767-7E5CB194-6B92-4CB5-887D-3C4BA7A14F9CQ34072513-6B0AADAB-D716-455C-8917-6CF36DE30B5BQ34469547-7EA0C28C-EBF9-4F27-A5AA-8EA3A8340F4BQ34581372-D15B5A84-B225-473B-9F65-5801F563C041Q35057043-F46CFA32-3EB7-4761-8784-DB3682A53C67Q35079056-B28131F2-0BC5-4687-ACC2-4C4D12777107Q35082603-9FE7F179-F164-4232-9395-000E5CD54A15Q35607381-9A546B8F-4C41-46B5-AC17-F82018F223C4Q35621241-4DFCCA66-46D7-4DAE-AFA1-E50AE9D03E97Q35634441-56908ED7-EDC3-451D-BC73-4BE8F016270FQ35955399-EAA0D2FA-1D17-465E-BA95-E17B830B8825Q36200666-A195121D-7050-48FC-9189-3248AC6E6EACQ36229280-6D020FA8-9F99-43FF-9757-4284717A1428Q36390962-E0DBFBDB-71BC-47E9-8A75-615B19AC40FDQ36410392-C0B92AE7-7696-4FC7-9B73-D9C4D82B893BQ36716762-7463632A-3306-4DB0-B3E4-DF6E2CDAB771Q37083732-811C3C75-1D71-477C-9B5D-34A5F09970BFQ37232224-5D28C139-184E-4A75-ACF1-BA00F70DA4D7Q37468529-B658D5C7-5E2A-4212-A3B4-CE106402B466Q37476181-A475D990-839E-4A03-A384-B4284209A3F0Q37665612-8432774F-3CF6-4E04-8122-6AC8CD4A47ACQ37913358-AE0E491B-8562-4BCA-A875-4A1EC6606880Q38056644-98B602B6-0771-4CD8-A309-1DBA1834D761Q38212216-8B481C7A-0C07-4A66-9CBF-7E91D8ACE374Q38524822-5273C5CD-9EAA-42BA-8EB8-C48E5CC67604Q39316208-A4F9E2CC-EA71-4F58-9745-4F8F0037909BQ39373538-81161596-51BE-48F6-BC9A-83E4A5306686Q39474693-C7E359FA-17C9-4915-B67D-80D3AFF0418EQ39543664-5DB2A45E-8D0B-41B9-B81E-8E90B6C4FA5EQ39760422-942660DC-C73A-4DF6-8FB2-41CCFDE3B517Q39789737-54DD3E82-3130-4868-9DBC-A685EBA09891Q39942512-4F91BF72-B95E-4908-A753-81ED828D0573Q39996943-D7C59FEE-13B8-4122-AAD4-56308A626707Q40108447-73FF73BF-176A-4B80-84D5-BE2C1B85B1C0Q41236727-90B42DAE-BC37-462C-B738-B16665C4A0C2Q41824540-3B8CB72A-C3E1-43E9-90D2-58E0DDF56565
P2860
Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Stem cells and gastric cancer: ...... l mixed intestinal metaplasia.
@ast
Stem cells and gastric cancer: ...... l mixed intestinal metaplasia.
@en
type
label
Stem cells and gastric cancer: ...... l mixed intestinal metaplasia.
@ast
Stem cells and gastric cancer: ...... l mixed intestinal metaplasia.
@en
prefLabel
Stem cells and gastric cancer: ...... l mixed intestinal metaplasia.
@ast
Stem cells and gastric cancer: ...... l mixed intestinal metaplasia.
@en
P2860
P1433
P1476
Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia
@en
P2093
Kenichi Inada
Masae Tatematsu
P2860
P304
P356
10.1111/J.1349-7006.2003.TB01409.X
P577
2003-02-01T00:00:00Z